ABPI calls for changes to “unsustainable” medicines pricing scheme

March 27, 2025

The UK’s MHRA launches consultation on draft guideline on individualised mRNA cancer immunotherapies

March 3, 2025

A New 2024 Code for the British Pharmaceutical Industry  – “The Future is Orange”

September 30, 2024

What does the new UK government mean for life sciences?

July 11, 2024

Implications of the New EU Product Liability Directive

June 12, 2024

BGMA refused permission for judicial review in relation to negotiation of the voluntary scheme

July 10, 2023

UK PMCPA publishes long-awaited guidance on use of social media

February 3, 2023

Concern over high Scheme Payments under the UK VPAS

September 28, 2022

New 2021 Code of Practice for the British Pharmaceutical Industry

January 25, 2021

Medical Devices and Compulsory Insurance in the EU

February 25, 2020